Compare OVID & ENVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OVID | ENVX |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 562.5M | 629.8M |
| IPO Year | 2017 | 2020 |
| Metric | OVID | ENVX |
|---|---|---|
| Price | $2.35 | $2.67 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 12 |
| Target Price | $5.92 | ★ $11.35 |
| AVG Volume (30 Days) | 1.4M | ★ 6.5M |
| Earning Date | 11-11-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.90 | ★ 40.94 |
| EPS | ★ N/A | N/A |
| Revenue | $7,252,000.00 | ★ $31,821,000.00 |
| Revenue This Year | N/A | $21.56 |
| Revenue Next Year | N/A | $100.06 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1181.27 | 37.91 |
| 52 Week Low | $1.18 | $2.48 |
| 52 Week High | $3.11 | $14.21 |
| Indicator | OVID | ENVX |
|---|---|---|
| Relative Strength Index (RSI) | 34.43 | 35.85 |
| Support Level | $2.18 | N/A |
| Resistance Level | $2.38 | $3.08 |
| Average True Range (ATR) | 0.13 | 0.18 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 6.31 | 34.45 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, the United States, Norway, Taiwan, and other regions.